Puma Biotechnology

pharmaceutical company

PBYI Nasdaq ISIN US74587V1070 SEC CIK 1401667
Follow Puma Biotechnology Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $55.1M +1.1% vs same quarter last year
Net income $6M −32.7% vs same quarter last year
EPS, diluted $0.11 −35.3% vs same quarter last year
Operating cash flow $14.6M +50.5% vs same quarter last year
Revenue by quarter
$59.1M
$46M
$52.4M
$54.5M
$75.5M
$44.8M
$56.5M
$55.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$228.4M$31.1M
FY24$230.5M$30.3M
FY23$235.6M$21.6M
FY22$228M$2K
FY21$253.2M-
FY20$225.1M−$60M
FY19$272.3M−$75.6M
FY18$251M−$113.6M
FY17$27.7M−$292M
FY16-−$276M
FY15-−$239.3M
FY14-−$142M
FY13-−$54.7M
FY12-−$74.4M
FY11-−$10.2M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2574.5%16.3%13.6%
FY2472.1%13.4%13.1%
FY2373.4%13.9%9.2%
FY2275.8%10.4%0%
FY2174.8%0.5%-
FY2082.5%−13.5%−26.7%
FY1986.5%−14.3%−27.8%
FY1886.2%−37.7%−45.3%
FY1779.9%−1056.1%−1054.6%
FY16---
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$41.7M
FY24$38.9M
FY23$26.9M
FY22−$15.8M
FY21$20.7M
FY20$727K
FY19$22.1M
FY18−$24.5M
FY17−$172.9M
FY16−$146M
FY15−$155.5M
FY14−$78.3M
FY13−$55.7M
FY12-
FY11−$2.1M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Puma Biotechnology
  • Healthcare median
−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPuma BiotechnologyHealthcare median
FY2513.6%−30.6%
FY2413.1%−47%
FY239.2%−58%
FY220%−80.4%
FY21-−71.8%
FY20−26.7%−62.2%
FY19−27.8%−46.2%
FY18−45.3%−49.6%
FY17−1054.6%−45.9%
FY16-−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%